Characteristics of weight gain in pregnancy among Canadian women

Christine Kowal1, Jennifer Kuk, Hala Tamim

  • 1Kinesiology and Health Science, York University, Toronto, ON, Canada. christinejkowal@gmail.com

The study aims to describe overall gestational weight gain among Canadian women and to assess demographic, socio-economic, maternal, and pregnancy-related characteristics of gestational weight gain including uncovering the predictors above or below the range recommended by Health Canada. This study proceeds as a secondary data analysis of the Maternity Experiences Survey targeting women aged ≥15 years who had singleton live births in the Canadian provinces and territories in 2005/2006. The outcome variable considered was gestational weight gain within and outside the recommended guidelines. Various factors including demographic, socio-economic, maternal, and pregnancy-related characteristics were considered using multivariate statistical techniques. Bootstrapping was performed to account for the complex sampling design. One-third of women gained within the recommended guideline (32.6%), 18.7% gained below, and 48.7% gained above the recommended guideline. More than half of overweight (67.6%) or obese women (60.0%) gained above the guideline, and women with lower socio-economic status were more likely to gain above the recommended range. Conversely, being an immigrant, multiparous, and having health problems during pregnancy were associated with less weight gain during pregnancy as well as higher odds of gaining insufficient weight to meet the minimal weight gain guideline. In Canada, almost half of the women gain above the recommended guideline for weight gain in pregnancy. The findings may be useful to design interventions that target those at risk of gaining outside of the recommended guidelines and to reduce outcomes associated with inadequate or excessive gestational weight gain.

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...